| Application no. and date | 12152463.1 (espacenet) (Federated) (European Patent Register), 20080307 | | Patent/reg. no. and date | DK/EP 2481409, 20180509 | | Publication date | 20120801 | | Priority no. and date | US 905735 P, 20070307, US 905767 P, 20070307, US 905669 P, 20070307, US 905787 P, 20070307, US 905662 P, 20070307, US 905750 P, 20070307, US 905734 P, 20070307, US 905672 P, 20070307, US 905663 P, 20070307, US 923248 P, 20070413, US 923456 P, 20070413 | | EP pub. no. and date |
EP 2481409 20120801 | | Effective date | | | Applicant/owner | Abraxis BioScience, LLC, 86 Morris Avenue
Summit, NJ 07901, US | | Applicant ref. no. | P65334DK01 | | Inventor | Trieu, Vuong, 4003 Jim Bowie
Agoura Hills, California 91301, US,
SOON-SHIONG, Patrick, 9922 Jefferson Boulevard
Culver City
CA 90232, US,
Desai, Neil P., 1343 Luna Vista Drive
Pacific Palisades
CA 90272, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/436 (2006.01) , A61K 45/06 (2006.01) , A61K 9/19 (2006.01) , A61K 9/51 (2006.01) , A61P 35/00 (2006.01) | | Title | Nanopartikel, der omfatter rapamycin og albumin som middel mod cancer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
